BDNF and depressive disorder: Since chronic GTS treatment did not significantly increase BDNF or NF-L expression in the hippocampus of normal mice, the protective role of GTS against corticosterone-induced depression-like behavior may result from reversing corticosterone-induced decrease in these plasticity-related proteins, thereby implying the recovery of neuroplasticity.